Aram Hezel
Chief of Hematology/Oncology at UR Medicine and Wilmot · University of Rochester Medicine
Credentials: · · · ·
History
PresentHematology/Oncology at UR Medicine and Wilmot Division · University of Rochester Medicine
- Present
Division of Hematology & Oncology · University of Rochester Medical Center
- 2017–2019
- 2003–2006
Research
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Cell · 2012 · 1,714 citations
Genetics and biology of pancreatic ductal adenocarcinoma
Review · Genes & Development · 2006 · First of 5 authors · 906 citations
The Oncologist · 2012 · 636 citations
19 papers · 11 as a resident
- AZ
14 papers
11 papers
- CF
10 papers
10 papers
10 papers
8 papers
8 papers · 1 as a resident
Grants
- 2013–2018
Genetics Pathways in Intra-Hepatic Cholangiocarcinoma
National Cancer Institute · R01
Contact PI · $1.6M · University of Rochester
- 2006–2012
Genomic Instability and The Roles of P53 and P19arf in Pancreatic Cancer
National Cancer Institute · K08
Contact PI · $712.5K · University of Rochester
Clinical trials
- 2026–2032
Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Principal investigator · Not yet recruiting · Phase 1
Aram Hezel
- 2015–2022
Regorafenib in Metastatic Colorectal Cancer
Principal investigator · Completed · Phase 2
University of Rochester
- 2010–2013
Principal investigator · Completed · Phase 2
University of Rochester
- 2009–2011
Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Principal investigator · Completed · Phase 2
Massachusetts General Hospital